{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:30:23Z","timestamp":1794947423597,"version":"4.9.1"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/nm.2807","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T14:35:57Z","timestamp":1341585357000},"page":"1028-1040","source":"Crossref","is-referenced-by-count":3409,"title":["Mechanisms of fibrosis: therapeutic translation for fibrotic disease"],"prefix":"10.1038","volume":"18","author":[{"given":"Thomas A","family":"Wynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumalai R","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,6]]},"reference":[{"key":"BFnm2807_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller, R. & Brenner, D.A. Liver fibrosis. J. Clin. Invest. 115, 209\u2013218 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnm2807_CR2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","volume":"208","author":"TA Wynn","year":"2011","unstructured":"Wynn, T.A. Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 208, 1339\u20131350 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnm2807_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn, T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199\u2013210 (2008).","journal-title":"J. Pathol."},{"key":"BFnm2807_CR4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/path.1427","volume":"200","author":"G Gabbiani","year":"2003","unstructured":"Gabbiani, G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200, 500\u2013503 (2003).","journal-title":"J. Pathol."},{"key":"BFnm2807_CR5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer 6, 392\u2013401 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm2807_CR6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-230X-10-79","volume":"10","author":"T Fujii","year":"2010","unstructured":"Fujii, T. et al. Mouse model of carbon tetrachloride\u2013induced liver fibrosis: histopathological changes and expression of CD133 and epidermal growth factor. BMC Gastroenterol. 10, 79 (2010).","journal-title":"BMC Gastroenterol."},{"key":"BFnm2807_CR7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrc1547","volume":"5","author":"J Chen","year":"2005","unstructured":"Chen, J. & Stubbe, J. Bleomycins: towards better therapeutics. Nat. Rev. Cancer 5, 102\u2013112 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm2807_CR8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","volume":"131","author":"CT Esmon","year":"2005","unstructured":"Esmon, C.T. The interactions between inflammation and coagulation. Br. J. Haematol. 131, 417\u2013430 (2005).","journal-title":"Br. J. Haematol."},{"key":"BFnm2807_CR9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1524-475X.2008.00410.x","volume":"16","author":"S Barrientos","year":"2008","unstructured":"Barrientos, S., Stojadinovic, O., Golinko, M.S., Brem, H. & Tomic-Canic, M. Growth factors and cytokines in wound healing. Wound Repair Regen. 16, 585\u2013601 (2008).","journal-title":"Wound Repair Regen."},{"key":"BFnm2807_CR10","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1038\/sj.bjp.0707603","volume":"153","author":"RC Chambers","year":"2008","unstructured":"Chambers, R.C. Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? Br. J. Pharmacol. 153, S367\u2013S378 (2008).","journal-title":"Br. J. Pharmacol."},{"key":"BFnm2807_CR11","first-page":"2550","volume":"119","author":"CJ Scotton","year":"2009","unstructured":"Scotton, C.J. et al. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J. Clin. Invest. 119, 2550\u20132563 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnm2807_CR12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","volume":"407","author":"SR Coughlin","year":"2000","unstructured":"Coughlin, S.R. Thrombin signalling and protease-activated receptors. Nature 407, 258\u2013264 (2000).","journal-title":"Nature"},{"key":"BFnm2807_CR13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.20054","volume":"39","author":"S Fiorucci","year":"2004","unstructured":"Fiorucci, S. et al. PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation. Hepatology 39, 365\u2013375 (2004).","journal-title":"Hepatology"},{"key":"BFnm2807_CR14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1538-7836.2008.03015.x","volume":"6","author":"QM Anstee","year":"2008","unstructured":"Anstee, Q.M. et al. Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies. J. Thromb. Haemost. 6, 1336\u20131343 (2008).","journal-title":"J. Thromb. Haemost."},{"key":"BFnm2807_CR15","first-page":"1238","volume":"21","author":"IR Wanless","year":"1995","unstructured":"Wanless, I.R. et al. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 21, 1238\u20131247 (1995).","journal-title":"Hepatology"},{"key":"BFnm2807_CR16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1084\/jem.20102510","volume":"208","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J. Exp. Med. 208, 1459\u20131471 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnm2807_CR17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI200522675","volume":"115","author":"JS Duffield","year":"2005","unstructured":"Duffield, J.S. et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115, 56\u201365 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnm2807_CR18","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1164\/ajrccm.161.5.9907065","volume":"161","author":"A Pardo","year":"2000","unstructured":"Pardo, A. et al. Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. Am. J. Respir. Crit. Care Med. 161, 1698\u20131704 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnm2807_CR19","first-page":"3213","volume":"119","author":"MK Connolly","year":"2009","unstructured":"Connolly, M.K. et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-\u03b1. J. Clin. Invest. 119, 3213\u20133225 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnm2807_CR20","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.4049\/jimmunol.150.9.4188","volume":"150","author":"Y Zhang","year":"1993","unstructured":"Zhang, Y., Lee, T.C., Guillemin, B., Yu, M.C. & Rom, W.N. Enhanced IL-1\u03b2 and tumor necrosis factor-\u03b1 release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J. Immunol. 150, 4188\u20134196 (1993).","journal-title":"J. Immunol."},{"key":"BFnm2807_CR21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1172\/JCI118029","volume":"96","author":"Y Miyazaki","year":"1995","unstructured":"Miyazaki, Y. et al. Expression of a tumor necrosis factor-\u03b1 transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J. Clin. Invest. 96, 250\u2013259 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnm2807_CR22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1172\/JCI12568","volume":"107","author":"M Kolb","year":"2001","unstructured":"Kolb, M., Margetts, P.J., Anthony, D.C., Pitossi, F. & Gauldie, J. Transient expression of IL-1\u03b2 induces acute lung injury and chronic repair leading to pulmonary fibrosis. J. Clin. Invest. 107, 1529\u20131536 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnm2807_CR23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/344245a0","volume":"344","author":"PF Piguet","year":"1990","unstructured":"Piguet, P.F., Collart, M.A., Grau, G.E., Sappino, A.P. & Vassalli, P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344, 245\u2013247 (1990).","journal-title":"Nature"},{"key":"BFnm2807_CR24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.170.3.655","volume":"170","author":"PF Piguet","year":"1989","unstructured":"Piguet, P.F., Collart, M.A., Grau, G.E., Kapanci, Y. & Vassalli, P. Tumor necrosis factor\/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170, 655\u2013663 (1989).","journal-title":"J. Exp. Med."},{"key":"BFnm2807_CR25","first-page":"651","volume":"143","author":"PF Piguet","year":"1993","unstructured":"Piguet, P.F., Ribaux, C., Karpuz, V., Grau, G.E. & Kapanci, Y. Expression and localization of tumor necrosis factor-\u03b1 and its mRNA in idiopathic pulmonary fibrosis. Am. J. Pathol. 143, 651\u2013655 (1993).","journal-title":"Am. J. Pathol."},{"key":"BFnm2807_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10753-008-9067-1","volume":"31","author":"IH Bahcecioglu","year":"2008","unstructured":"Bahcecioglu, I.H. et al. Hepatoprotective effect of infliximab, an anti\u2013TNF-\u03b1 agent, on carbon tetrachloride\u2013induced hepatic fibrosis. Inflammation 31, 215\u2013221 (2008).","journal-title":"Inflammation"},{"key":"BFnm2807_CR27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2010.09.010","volume":"97","author":"I Nawroth","year":"2010","unstructured":"Nawroth, I. et al. Intraperitoneal administration of chitosan\/DsiRNA nanoparticles targeting TNF-\u03b1 prevents radiation-induced fibrosis. Radiother. Oncol. 97, 143\u2013148 (2010).","journal-title":"Radiother. Oncol."},{"key":"BFnm2807_CR28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gut.2005.071118","volume":"55","author":"K Tomita","year":"2006","unstructured":"Tomita, K. et al. Tumour necrosis factor-\u03b1 signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 55, 415\u2013424 (2006).","journal-title":"Gut"},{"key":"BFnm2807_CR29","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.200709-1446OC","volume":"178","author":"G Raghu","year":"2008","unstructured":"Raghu, G. et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 178, 948\u2013955 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnm2807_CR30","first-page":"3786","volume":"117","author":"P Gasse","year":"2007","unstructured":"Gasse, P. et al. IL-1R1\/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J. Clin. Invest. 117, 3786\u20133799 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnm2807_CR31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00005-009-0024-y","volume":"57","author":"M Bujak","year":"2009","unstructured":"Bujak, M. & Frangogiannis, N.G. The role of IL-1 in the pathogenesis of heart disease. Arch. Immunol. Ther. Exp. (Warsz.) 57, 165\u2013176 (2009).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"BFnm2807_CR32","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1093\/ndt\/gfp214","volume":"24","author":"LK Jones","year":"2009","unstructured":"Jones, L.K. et al. IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol. Dial. Transplant. 24, 3024\u20133032 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnm2807_CR33","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jhep.2011.01.048","volume":"55","author":"Y Kamari","year":"2011","unstructured":"Kamari, Y. et al. Lack of interleukin-1\u03b1 or interleukin-1\u03b2 inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J. Hepatol. 55, 1086\u20131094 (2011).","journal-title":"J. Hepatol."},{"key":"BFnm2807_CR34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0272-6386(01)80132-3","volume":"37","author":"JM Fan","year":"2001","unstructured":"Fan, J.M. et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-\u03b21\u2013dependent mechanism in vitro. Am. J. Kidney Dis. 37, 820\u2013831 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnm2807_CR35","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1600-6143.2009.02706.x","volume":"9","author":"JA Diaz","year":"2009","unstructured":"Diaz, J.A. et al. Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Am. J. Transplant. 9, 1773\u20131783 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnm2807_CR36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jlb.66.4.601","volume":"66","author":"M Natsume","year":"1999","unstructured":"Natsume, M. et al. Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride\u2013treated IL-6\u2013deficient mice. J. Leukoc. Biol. 66, 601\u2013608 (1999).","journal-title":"J. Leukoc. Biol."},{"key":"BFnm2807_CR37","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3748\/wjg.v13.i22.3056","volume":"13","author":"F Verrecchia","year":"2007","unstructured":"Verrecchia, F. & Mauviel, A. Transforming growth factor-\u03b2 and fibrosis. World J. Gastroenterol. 13, 3056\u20133062 (2007).","journal-title":"World J. Gastroenterol."},{"key":"BFnm2807_CR38","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20030917","volume":"198","author":"A Kitani","year":"2003","unstructured":"Kitani, A. et al. Transforming growth factor (TGF)-\u03b21\u2013producing regulatory T cells induce Smad-mediated interleukin-10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-\u03b21\u2013mediated fibrosis. J. Exp. Med. 198, 1179\u20131188 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnm2807_CR39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","volume":"30","author":"TA Wynn","year":"2010","unstructured":"Wynn, T.A. & Barron, L. Macrophages: master regulators of inflammation and fibrosis. Semin. Liver Dis. 30, 245\u2013257 (2010).","journal-title":"Semin. Liver Dis."},{"key":"BFnm2807_CR40","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","volume":"5","author":"S Gordon","year":"2005","unstructured":"Gordon, S. & Taylor, P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953\u2013964 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm2807_CR41","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.4049\/jimmunol.167.11.6533","volume":"167","author":"M Hesse","year":"2001","unstructured":"Hesse, M. et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1\/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of l-arginine metabolism. J. Immunol. 167, 6533\u20136544 (2001).","journal-title":"J. Immunol."},{"key":"BFnm2807_CR42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/cimm.2000.1687","volume":"204","author":"E Song","year":"2000","unstructured":"Song, E. et al. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell. Immunol. 204, 19\u201328 (2000).","journal-title":"Cell. Immunol."},{"key":"BFnm2807_CR43","doi-asserted-by":"crossref","first-page":"L341","DOI":"10.1152\/ajplung.00122.2010","volume":"300","author":"L Sun","year":"2011","unstructured":"Sun, L. et al. New concepts of IL-10\u2013induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2\/CCR2 axis. Am. J. Physiol. Lung Cell Mol. Physiol. 300, L341\u2013L353 (2011).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"BFnm2807_CR44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1074-7613(04)00107-4","volume":"20","author":"DR Herbert","year":"2004","unstructured":"Herbert, D.R. et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20, 623\u2013635 (2004).","journal-title":"Immunity"},{"key":"BFnm2807_CR45","doi-asserted-by":"crossref","first-page":"e1000371","DOI":"10.1371\/journal.ppat.1000371","volume":"5","author":"JT Pesce","year":"2009","unstructured":"Pesce, J.T. et al. Arginase-1\u2013expressing macrophages suppress TH2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 5, e1000371 (2009).","journal-title":"PLoS Pathog."},{"key":"BFnm2807_CR46","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray, P.J. & Wynn, T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723\u2013737 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm2807_CR47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","volume":"391","author":"M Ricote","year":"1998","unstructured":"Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J. & Glass, C.K. The peroxisome proliferator\u2013activated receptor-\u03b3 is a negative regulator of macrophage activation. Nature 391, 79\u201382 (1998).","journal-title":"Nature"},{"key":"BFnm2807_CR48","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nature05894","volume":"447","author":"JI Odegaard","year":"2007","unstructured":"Odegaard, J.I. et al. Macrophage-specific PPAR-\u03b3 controls alternative activation and improves insulin resistance. Nature 447, 1116\u20131120 (2007).","journal-title":"Nature"},{"key":"BFnm2807_CR49","doi-asserted-by":"crossref","first-page":"e15909","DOI":"10.1371\/journal.pone.0015909","volume":"6","author":"AA Kulkarni","year":"2011","unstructured":"Kulkarni, A.A. et al. PPAR-\u03b3 ligands repress TGF-\u03b2\u2013induced myofibroblast differentiation by targeting the PI3K\/Akt pathway: implications for therapy of fibrosis. PLoS ONE 6, e15909 (2011).","journal-title":"PLoS ONE"},{"key":"BFnm2807_CR50","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.HYP.0000083511.91817.B1","volume":"42","author":"M Iglarz","year":"2003","unstructured":"Iglarz, M. et al. Peroxisome proliferator\u2013activated receptor-\u03b1 and receptor-\u03b3 activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension. Hypertension 42, 737\u2013743 (2003).","journal-title":"Hypertension"},{"key":"BFnm2807_CR51","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00011-010-0226-0","volume":"59","author":"L Yang","year":"2010","unstructured":"Yang, L., Stimpson, S.A., Chen, L., Wallace Harrington, W. & Rockey, D.C. Effectiveness of the PPAR-\u03b3 agonist, GW570, in liver fibrosis. Inflamm. Res. 59, 1061\u20131071 (2010).","journal-title":"Inflamm. Res."},{"key":"BFnm2807_CR52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/labinvest.2008.104","volume":"89","author":"T Kawai","year":"2009","unstructured":"Kawai, T. et al. PPAR-\u03b3 agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-\u03b2. Lab. Invest. 89, 47\u201358 (2009).","journal-title":"Lab. Invest."},{"key":"BFnm2807_CR53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000168676","volume":"77","author":"Y Aoki","year":"2009","unstructured":"Aoki, Y. et al. Pioglitazone, a peroxisome proliferator\u2013activated receptor-\u03b3 ligand, suppresses bleomycin-induced acute lung injury and fibrosis. Respiration 77, 311\u2013319 (2009).","journal-title":"Respiration"},{"key":"BFnm2807_CR54","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/HYPERTENSIONAHA.108.123158","volume":"53","author":"SP Levick","year":"2009","unstructured":"Levick, S.P. et al. Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart. Hypertension 53, 1041\u20131047 (2009).","journal-title":"Hypertension"},{"key":"BFnm2807_CR55","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1128\/IAI.74.3.1471-1479.2006","volume":"74","author":"RM Reiman","year":"2006","unstructured":"Reiman, R.M. et al. Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect. Immun. 74, 1471\u20131479 (2006).","journal-title":"Infect. Immun."},{"key":"BFnm2807_CR56","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1165\/ajrcmb.17.3.2733","volume":"17","author":"EM Minshall","year":"1997","unstructured":"Minshall, E.M. et al. Eosinophil-associated TGF-\u03b21 mRNA expression and airways fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 17, 326\u2013333 (1997).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFnm2807_CR57","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1126\/science.1100283","volume":"305","author":"AA Humbles","year":"2004","unstructured":"Humbles, A.A. et al. A critical role for eosinophils in allergic airways remodeling. Science 305, 1776\u20131779 (2004).","journal-title":"Science"},{"key":"BFnm2807_CR58","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.1073\/pnas.96.17.9660","volume":"96","author":"F Levi-Schaffer","year":"1999","unstructured":"Levi-Schaffer, F. et al. Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor-\u03b2 (TGF-\u03b2). Proc. Natl. Acad. Sci. USA 96, 9660\u20139665 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2807_CR59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1378\/chest.92.1.51","volume":"92","author":"MW Peterson","year":"1987","unstructured":"Peterson, M.W., Monick, M. & Hunninghake, G.W. Prognostic role of eosinophils in pulmonary fibrosis. Chest 92, 51\u201356 (1987).","journal-title":"Chest"},{"key":"BFnm2807_CR60","first-page":"3","volume":"154","author":"HS Gilbert","year":"1984","unstructured":"Gilbert, H.S. Myelofibrosis revisited: characterization and classification of myelofibrosis in the setting of myeloproliferative disease. Prog. Clin. Biol. Res. 154, 3\u201317 (1984).","journal-title":"Prog. Clin. Biol. Res."},{"key":"BFnm2807_CR61","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20092121","volume":"207","author":"MS Wilson","year":"2010","unstructured":"Wilson, M.S. et al. Bleomycin and IL-1\u03b2\u2013mediated pulmonary fibrosis is IL-17A dependent. J. Exp. Med. 207, 535\u2013552 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnm2807_CR62","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.4049\/jimmunol.0902446","volume":"183","author":"SM Faust","year":"2009","unstructured":"Faust, S.M. et al. Role of T cell TGF-\u03b2 signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J. Immunol. 183, 7297\u20137306 (2009).","journal-title":"J. Immunol."},{"key":"BFnm2807_CR63","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1600-6143.2011.03482.x","volume":"11","author":"L Fan","year":"2011","unstructured":"Fan, L. et al. Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation. Am. J. Transplant. 11, 911\u2013922 (2011).","journal-title":"Am. J. Transplant."},{"key":"BFnm2807_CR64","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yexmp.2009.06.001","volume":"87","author":"W Feng","year":"2009","unstructured":"Feng, W. et al. IL-17 induces myocardial fibrosis and enhances RANKL\/OPG and MMP\/TIMP signaling in isoproterenol-induced heart failure. Exp. Mol. Pathol. 87, 212\u2013218 (2009).","journal-title":"Exp. Mol. Pathol."},{"key":"BFnm2807_CR65","first-page":"385","volume":"27","author":"L Wang","year":"2011","unstructured":"Wang, L., Chen, S.J. & Xu, K.S. IL-17 expression is correlated with hepatitis B\u2013related liver diseases and fibrosis. Int. J. Mol. Med. 27, 385\u2013392 (2011).","journal-title":"Int. J. Mol. Med."},{"key":"BFnm2807_CR66","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.4049\/jimmunol.162.4.2347","volume":"162","author":"M Laan","year":"1999","unstructured":"Laan, M. et al. Neutrophil recruitment by human IL-17 via CXC chemokine release in the airways. J. Immunol. 162, 2347\u20132352 (1999).","journal-title":"J. Immunol."},{"key":"BFnm2807_CR67","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clim.2011.07.003","volume":"141","author":"F Zhu","year":"2011","unstructured":"Zhu, F. et al. IL-17 induces apoptosis of vascular endothelial cells\u2014a potential mechanism for human acute coronary syndrome. Clin. Immunol. 141, 152\u2013160 (2011).","journal-title":"Clin. Immunol."},{"key":"BFnm2807_CR68","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1378\/chest.07-1948","volume":"133","author":"BW Kinder","year":"2008","unstructured":"Kinder, B.W. et al. Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest 133, 226\u2013232 (2008).","journal-title":"Chest"},{"key":"BFnm2807_CR69","doi-asserted-by":"crossref","first-page":"e23185","DOI":"10.1371\/journal.pone.0023185","volume":"6","author":"P Gasse","year":"2011","unstructured":"Gasse, P. et al. IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS ONE 6, e23185 (2011).","journal-title":"PLoS ONE"},{"key":"BFnm2807_CR70","doi-asserted-by":"crossref","first-page":"H3356","DOI":"10.1152\/ajpheart.00928.2007","volume":"293","author":"DM Cortez","year":"2007","unstructured":"Cortez, D.M. et al. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1\/2-dependent C\/EBP-\u03b2, NF-\u03baB and AP-1 activation. Am. J. Physiol. Heart Circ. Physiol. 293, H3356\u2013H3365 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnm2807_CR71","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/376594a0","volume":"376","author":"TA Wynn","year":"1995","unstructured":"Wynn, T.A. et al. An IL-12\u2013based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376, 594\u2013596 (1995).","journal-title":"Nature"},{"key":"BFnm2807_CR72","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"TA Wynn","year":"2004","unstructured":"Wynn, T.A. Fibrotic disease and the TH1\/TH2 paradigm. Nat. Rev. Immunol. 4, 583\u2013594 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm2807_CR73","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2619::AID-IMMU2619>3.0.CO;2-M","volume":"28","author":"C Ong","year":"1998","unstructured":"Ong, C., Wong, C., Roberts, C.R., Teh, H.S. & Jirik, F.R. Anti\u2013IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma. Eur. J. Immunol. 28, 2619\u20132629 (1998).","journal-title":"Eur. J. Immunol."},{"key":"BFnm2807_CR74","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1172\/JCI7325","volume":"104","author":"MG Chiaramonte","year":"1999","unstructured":"Chiaramonte, M.G., Donaldson, D.D., Cheever, A.W. & Wynn, T.A. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T helper type 2\u2013dominated inflammatory response. J. Clin. Invest. 104, 777\u2013785 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnm2807_CR75","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cyto.2004.08.007","volume":"28","author":"G Yang","year":"2004","unstructured":"Yang, G. et al. Anti\u2013IL-13 monoclonal antibody inhibits airway hyper-responsiveness, inflammation and airway remodeling. Cytokine 28, 224\u2013232 (2004).","journal-title":"Cytokine"},{"key":"BFnm2807_CR76","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.biocel.2008.02.016","volume":"40","author":"LA Murray","year":"2008","unstructured":"Murray, L.A. et al. Hyper-responsiveness of IPF\/UIP fibroblasts: interplay between TGF-\u03b21, IL-13 and CCL2. Int. J. Biochem. Cell Biol. 40, 2174\u20132182 (2008).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFnm2807_CR77","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.4049\/jimmunol.172.7.4068","volume":"172","author":"JE Kolodsick","year":"2004","unstructured":"Kolodsick, J.E. et al. Protection from fluorescein isothiocyanate\u2013induced fibrosis in IL-13\u2013deficient, but not IL-4\u2013deficient, mice results from impaired collagen synthesis by fibroblasts. J. Immunol. 172, 4068\u20134076 (2004).","journal-title":"J. Immunol."},{"key":"BFnm2807_CR78","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.cyto.2011.08.030","volume":"56","author":"P Fuschiotti","year":"2011","unstructured":"Fuschiotti, P. Role of IL-13 in systemic sclerosis. Cytokine 56, 544\u2013549 (2011).","journal-title":"Cytokine"},{"key":"BFnm2807_CR79","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.4049\/jimmunol.1100504","volume":"186","author":"MH Oh","year":"2011","unstructured":"Oh, M.H. et al. IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin. J. Immunol. 186, 7232\u20137242 (2011).","journal-title":"J. Immunol."},{"key":"BFnm2807_CR80","first-page":"383","volume":"26","author":"G Han","year":"2011","unstructured":"Han, G., Zhang, H., Xie, C.H. & Zhou, Y.F. TH2-like immune response in radiation-induced lung fibrosis. Oncol. Rep. 26, 383\u2013388 (2011).","journal-title":"Oncol. Rep."},{"key":"BFnm2807_CR81","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1074-7613(02)00453-3","volume":"17","author":"F Heller","year":"2002","unstructured":"Heller, F., Fuss, I.J., Nieuwenhuis, E.E., Blumberg, R.S. & Strober, W. Oxazolone colitis, a TH2 colitis model resembling ulcerative colitis, is mediated by IL-13\u2013producing NKT cells. Immunity 17, 629\u2013638 (2002).","journal-title":"Immunity"},{"key":"BFnm2807_CR82","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.22934","volume":"50","author":"HL Weng","year":"2009","unstructured":"Weng, H.L. et al. The etiology of liver damage imparts cytokines transforming growth factor-\u03b21 or interleukin-13 as driving forces in fibrogenesis. Hepatology 50, 230\u2013243 (2009).","journal-title":"Hepatology"},{"key":"BFnm2807_CR83","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.4049\/jimmunol.181.7.4656","volume":"181","author":"T Shimamura","year":"2008","unstructured":"Shimamura, T. et al. Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R\u2013directed cytotoxin in a rat model. J. Immunol. 181, 4656\u20134665 (2008).","journal-title":"J. Immunol."},{"key":"BFnm2807_CR84","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.194.6.809","volume":"194","author":"CG Lee","year":"2001","unstructured":"Lee, C.G. et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor-\u03b21. J. Exp. Med. 194, 809\u2013822 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnm2807_CR85","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.4049\/jimmunol.1003260","volume":"187","author":"Y Liu","year":"2011","unstructured":"Liu, Y. et al. IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-\u03b2\u2013independent Smad signaling. J. Immunol. 187, 2814\u20132823 (2011).","journal-title":"J. Immunol."},{"key":"BFnm2807_CR86","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.4049\/jimmunol.173.6.4020","volume":"173","author":"M Kaviratne","year":"2004","unstructured":"Kaviratne, M. et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-\u03b2 independent. J. Immunol. 173, 4020\u20134029 (2004).","journal-title":"J. Immunol."},{"key":"BFnm2807_CR87","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nm734","volume":"8","author":"DA Kuperman","year":"2002","unstructured":"Kuperman, D.A. et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8, 885\u2013889 (2002).","journal-title":"Nat. Med."},{"key":"BFnm2807_CR88","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1165\/ajrcmb.25.4.4522","volume":"25","author":"JH Lee","year":"2001","unstructured":"Lee, J.H. et al. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am. J. Respir. Cell Mol. Biol. 25, 474\u2013485 (2001).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFnm2807_CR89","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.gastro.2010.09.047","volume":"140","author":"MS Wilson","year":"2011","unstructured":"Wilson, M.S. et al. Colitis and intestinal inflammation in IL10\u2212\/\u2212 mice results from IL-13R\u03b12\u2013mediated attenuation of IL-13 activity. Gastroenterology 140, 254\u2013264 e2 (2011).","journal-title":"Gastroenterology"},{"key":"BFnm2807_CR90","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ni1544","volume":"9","author":"TR Ramalingam","year":"2008","unstructured":"Ramalingam, T.R. et al. Unique functions of the type II interleukin-4 receptor identified in mice lacking the interleukin-13 receptor-\u03b11 chain. Nat. Immunol. 9, 25\u201333 (2008).","journal-title":"Nat. Immunol."},{"key":"BFnm2807_CR91","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1084\/jem.20020903","volume":"197","author":"MG Chiaramonte","year":"2003","unstructured":"Chiaramonte, M.G. et al. Regulation and function of the interleukin-13 receptor-\u03b12 during a T helper cell type 2\u2013dominant immune response. J. Exp. Med. 197, 687\u2013701 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnm2807_CR92","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1053\/j.gastro.2011.08.008","volume":"141","author":"MM Mentink-Kane","year":"2011","unstructured":"Mentink-Kane, M.M. et al. Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13R\u03b12. Gastroenterology 141, 2200\u20132209 (2011).","journal-title":"Gastroenterology"},{"key":"BFnm2807_CR93","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.0105-2896.2004.00210.x","volume":"202","author":"MM Mentink-Kane","year":"2004","unstructured":"Mentink-Kane, M.M. & Wynn, T.A. Opposing roles for IL-13 and IL-13 receptor-\u03b12 in health and disease. Immunol. Rev. 202, 191\u2013202 (2004).","journal-title":"Immunol. Rev."},{"key":"BFnm2807_CR94","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hep.510230538","volume":"23","author":"GS Baroni","year":"1996","unstructured":"Baroni, G.S. et al. Interferon-\u03b3 decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 23, 1189\u20131199 (1996).","journal-title":"Hepatology"},{"key":"BFnm2807_CR95","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0885-4505(86)90124-6","volume":"36","author":"SN Giri","year":"1986","unstructured":"Giri, S.N., Hyde, D.M. & Marafino, B.J. Jr. Ameliorating effect of murine interferon-\u03b3 on bleomycin-induced lung collagen fibrosis in mice. Biochem. Med. Metab. Biol. 36, 194\u2013197 (1986).","journal-title":"Biochem. Med. Metab. Biol."},{"key":"BFnm2807_CR96","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1046\/j.1523-1755.1999.00775.x","volume":"56","author":"SD Oldroyd","year":"1999","unstructured":"Oldroyd, S.D., Thomas, G.L., Gabbiani, G. & El Nahas, A.M. Interferon-\u03b3 inhibits experimental renal fibrosis. Kidney Int. 56, 2116\u20132127 (1999).","journal-title":"Kidney Int."},{"key":"BFnm2807_CR97","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0002-9440(10)61211-4","volume":"167","author":"JH Kim","year":"2005","unstructured":"Kim, J.H. et al. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-\u03b3. Am. J. Pathol. 167, 1231\u20131241 (2005).","journal-title":"Am. J. Pathol."},{"key":"BFnm2807_CR98","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.gastro.2007.09.034","volume":"134","author":"WI Jeong","year":"2008","unstructured":"Jeong, W.I., Park, O. & Gao, B. Abrogation of the antifibrotic effects of natural killer cells\/interferon-\u03b3 contributes to alcohol acceleration of liver fibrosis. Gastroenterology 134, 248\u2013258 (2008).","journal-title":"Gastroenterology"},{"key":"BFnm2807_CR99","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/17826","volume":"397","author":"L Ulloa","year":"1999","unstructured":"Ulloa, L., Doody, J. & Massague, J. Inhibition of transforming growth factor-\u03b2\/SMAD signalling by the interferon-\u03b3\/STAT pathway. Nature 397, 710\u2013713 (1999).","journal-title":"Nature"},{"key":"BFnm2807_CR100","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3109\/01902149509050842","volume":"21","author":"G Gurujeyalakshmi","year":"1995","unstructured":"Gurujeyalakshmi, G. & Giri, S.N. Molecular mechanisms of antifibrotic effect of interferon-\u03b3 in bleomycin mouse model of lung fibrosis: downregulation of TGF-\u03b2 and procollagen I and III gene expression. Exp. Lung Res. 21, 791\u2013808 (1995).","journal-title":"Exp. Lung Res."},{"key":"BFnm2807_CR101","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1189\/jlb.1107782","volume":"83","author":"DD Shao","year":"2008","unstructured":"Shao, D.D., Suresh, R., Vakil, V., Gomer, R.H. & Pilling, D. Pivotal advance: TH1 cytokines inhibit, and TH2 cytokines promote fibrocyte differentiation. J. Leukoc. Biol. 83, 1323\u20131333 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"BFnm2807_CR102","doi-asserted-by":"crossref","first-page":"L92","DOI":"10.1152\/ajplung.2001.281.1.L92","volume":"281","author":"MP Keane","year":"2001","unstructured":"Keane, M.P., Belperio, J.A., Burdick, M.D. & Strieter, R.M. IL-12 attenuates bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 281, L92\u2013L97 (2001).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"BFnm2807_CR103","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(09)60551-1","volume":"374","author":"TE King Jr.","year":"2009","unstructured":"King, T.E. Jr. et al. Effect of interferon-\u03b3-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet 374, 222\u2013228 (2009).","journal-title":"Lancet"},{"key":"BFnm2807_CR104","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1164\/rccm.200812-1936OC","volume":"179","author":"I Kotsianidis","year":"2009","unstructured":"Kotsianidis, I. et al. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 179, 1121\u20131130 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnm2807_CR105","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1172\/JCI37662","volume":"119","author":"SA Vetrone","year":"2009","unstructured":"Vetrone, S.A. et al. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-\u03b2. J. Clin. Invest. 119, 1583\u20131594 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnm2807_CR106","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1097\/HJH.0b013e328349c62d","volume":"29","author":"P Kanellakis","year":"2011","unstructured":"Kanellakis, P., Dinh, T.N., Agrotis, A. & Bobik, A. CD4+CD25+Foxp3+ regulatory T cells suppress cardiac fibrosis in the hypertensive heart. J. Hypertens. 29, 1820\u20131828 (2011).","journal-title":"J. Hypertens."},{"key":"BFnm2807_CR107","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.trim.2010.09.002","volume":"24","author":"JL Zhang","year":"2010","unstructured":"Zhang, J.L. et al. CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by upregulation of Foxp3+ regulatory T cells in the target tissue: kidney. Transpl. Immunol. 24, 17\u201325 (2010).","journal-title":"Transpl. Immunol."},{"key":"BFnm2807_CR108","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2009.12.013","volume":"52","author":"MA Claassen","year":"2010","unstructured":"Claassen, M.A., de Knegt, R.J., Tilanus, H.W., Janssen, H.L. & Boonstra, A. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C\u2013infected patients and limit the extent of fibrosis. J. Hepatol. 52, 315\u2013321 (2010).","journal-title":"J. Hepatol."},{"key":"BFnm2807_CR109","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/510852","volume":"195","author":"JD Estes","year":"2007","unstructured":"Estes, J.D. et al. Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor-\u03b21\u2013positive regulatory T cells and begins in early infection. J. Infect. Dis. 195, 551\u2013561 (2007).","journal-title":"J. Infect. Dis."},{"key":"BFnm2807_CR110","doi-asserted-by":"crossref","first-page":"e15404","DOI":"10.1371\/journal.pone.0015404","volume":"5","author":"F Liu","year":"2010","unstructured":"Liu, F. et al. CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice. PLoS ONE 5, e15404 (2010).","journal-title":"PLoS ONE"},{"key":"BFnm2807_CR111","doi-asserted-by":"crossref","first-page":"e25450","DOI":"10.1371\/journal.pone.0025450","volume":"6","author":"HA Baarsma","year":"2011","unstructured":"Baarsma, H.A. et al. Activation of Wnt\/\u03b2-catenin signaling in pulmonary fibroblasts by TGF-\u03b2 is increased in chronic obstructive pulmonary disease. PLoS ONE 6, e25450 (2011).","journal-title":"PLoS ONE"},{"key":"BFnm2807_CR112","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/art.30312","volume":"63","author":"J Wei","year":"2011","unstructured":"Wei, J. et al. Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? Arthritis Rheum. 63, 1707\u20131717 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnm2807_CR113","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1681\/ASN.2004110949","volume":"16","author":"K Surendran","year":"2005","unstructured":"Surendran, K., Schiavi, S. & Hruska, K.A. Wnt-dependent \u03b2-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J. Am. Soc. Nephrol. 16, 2373\u20132384 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnm2807_CR114","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2011.255","volume":"80","author":"D Wang","year":"2011","unstructured":"Wang, D., Dai, C., Li, Y. & Liu, Y. Canonical Wnt\/\u03b2-catenin signaling mediates transforming growth factor-\u03b21\u2013driven podocyte injury and proteinuria. Kidney Int. 80, 1159\u20131169 (2011).","journal-title":"Kidney Int."},{"key":"BFnm2807_CR115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jhep.2006.03.016","volume":"45","author":"F Jiang","year":"2006","unstructured":"Jiang, F., Parsons, C.J. & Stefanovic, B. Gene-expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J. Hepatol. 45, 401\u2013409 (2006).","journal-title":"J. Hepatol."},{"key":"BFnm2807_CR116","first-page":"772","volume":"119","author":"M K\u00f6nigshoff","year":"2009","unstructured":"K\u00f6nigshoff, M. et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J. Clin. Invest. 119, 772\u2013787 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnm2807_CR117","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1091\/mbc.12.9.2730","volume":"12","author":"B Hinz","year":"2001","unstructured":"Hinz, B., Celetta, G., Tomasek, J.J., Gabbiani, G. & Chaponnier, C. \u03b1-smooth muscle actin expression upregulates fibroblast contractile activity. Mol. Biol. Cell 12, 2730\u20132741 (2001).","journal-title":"Mol. Biol. Cell"},{"key":"BFnm2807_CR118","doi-asserted-by":"crossref","first-page":"17435","DOI":"10.1074\/jbc.M110.137273","volume":"286","author":"RL Heise","year":"2011","unstructured":"Heise, R.L., Stober, V., Cheluvaraju, C., Hollingsworth, J.W. & Garantziotis, S. Mechanical stretch induces epithelial-mesenchymal transition in alveolar epithelia via hyaluronan activation of innate immunity. J. Biol. Chem. 286, 17435\u201317444 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFnm2807_CR119","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/ATVBAHA.110.220061","volume":"31","author":"JH Chen","year":"2011","unstructured":"Chen, J.H., Chen, W.L., Sider, K.L., Yip, C.Y. & Simmons, C.A. \u03b2-catenin mediates mechanically regulated, transforming growth factor-\u03b21\u2013induced myofibroblast differentiation of aortic valve interstitial cells. Arterioscler. Thromb. Vasc. Biol. 31, 590\u2013597 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnm2807_CR120","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1039\/c2ib00149g","volume":"4","author":"JL Balestrini","year":"2012","unstructured":"Balestrini, J.L., Chaudhry, S., Sarrazy, V., Koehler, A. & Hinz, B. The mechanical memory of lung myofibroblasts. Integr. Biol. 4, 410\u2013421 (2012).","journal-title":"Integr. Biol."},{"key":"BFnm2807_CR121","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11926-009-0017-1","volume":"11","author":"B Hinz","year":"2009","unstructured":"Hinz, B. Tissue stiffness, latent TGF-\u03b21 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. Curr. Rheumatol. Rep. 11, 120\u2013126 (2009).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnm2807_CR122","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nm.2135","volume":"16","author":"W Bechtel","year":"2010","unstructured":"Bechtel, W. et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat. Med. 16, 544\u2013550 (2010).","journal-title":"Nat. Med."},{"key":"BFnm2807_CR123","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/MCB.01527-09","volume":"30","author":"WR Coward","year":"2010","unstructured":"Coward, W.R., Watts, K., Feghali-Bostwick, C.A., Jenkins, G. & Pang, L. Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis. Mol. Cell Biol. 30, 2874\u20132886 (2010).","journal-title":"Mol. Cell Biol."},{"key":"BFnm2807_CR124","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1165\/rcmb.2007-0322OC","volume":"39","author":"YY Sanders","year":"2008","unstructured":"Sanders, Y.Y. et al. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 39, 610\u2013618 (2008).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFnm2807_CR125","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0028-1091980","volume":"28","author":"H Malhi","year":"2008","unstructured":"Malhi, H. & Gores, G.J. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin. Liver Dis. 28, 360\u2013369 (2008).","journal-title":"Semin. Liver Dis."},{"key":"BFnm2807_CR126","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1164\/rccm.200802-313OC","volume":"178","author":"M Korfei","year":"2008","unstructured":"Korfei, M. et al. Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 178, 838\u2013846 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnm2807_CR127","doi-asserted-by":"crossref","first-page":"L1119","DOI":"10.1152\/ajplung.00382.2007","volume":"294","author":"WE Lawson","year":"2008","unstructured":"Lawson, W.E. et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am. J. Physiol. Lung Cell Mol. Physiol. 294, L1119\u2013L1126 (2008).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"BFnm2807_CR128","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMra0903373","volume":"361","author":"RT Calado","year":"2009","unstructured":"Calado, R.T. & Young, N.S. Telomere diseases. N. Engl. J. Med. 361, 2353\u20132365 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2807_CR129","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0701009104","volume":"104","author":"KD Tsakiri","year":"2007","unstructured":"Tsakiri, K.D. et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl. Acad. Sci. USA 104, 7552\u20137557 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2807_CR130","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1164\/rccm.200804-550OC","volume":"178","author":"JT Cronkhite","year":"2008","unstructured":"Cronkhite, J.T. et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 178, 729\u2013737 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnm2807_CR131","doi-asserted-by":"crossref","first-page":"13051","DOI":"10.1073\/pnas.0804280105","volume":"105","author":"JK Alder","year":"2008","unstructured":"Alder, J.K. et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 105, 13051\u201313056 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2807_CR132","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa066157","volume":"356","author":"MY Armanios","year":"2007","unstructured":"Armanios, M.Y. et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356, 1317\u20131326 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2807_CR133","doi-asserted-by":"crossref","first-page":"L57","DOI":"10.1152\/ajplung.90411.2008","volume":"296","author":"J Lee","year":"2009","unstructured":"Lee, J. et al. Lung alveolar integrity is compromised by telomere shortening in telomerase-null mice. Am. J. Physiol. Lung Cell Mol. Physiol. 296, L57\u2013L70 (2009).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"BFnm2807_CR134","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1165\/rcmb.2005-0252OC","volume":"34","author":"T Liu","year":"2006","unstructured":"Liu, T. et al. Telomerase regulation of myofibroblast differentiation. Am. J. Respir. Cell Mol. Biol. 34, 625\u2013633 (2006).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFnm2807_CR135","doi-asserted-by":"crossref","first-page":"25588","DOI":"10.1074\/jbc.M602381200","volume":"281","author":"H Li","year":"2006","unstructured":"Li, H., Xu, D., Li, J., Berndt, M.C. & Liu, J.P. Transforming growth factor-\u03b2 suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene. J. Biol. Chem. 281, 25588\u201325600 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnm2807_CR136","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0047-6374(01)00380-3","volume":"123","author":"CJ Proctor","year":"2002","unstructured":"Proctor, C.J. & Kirkwood, T.B. Modelling telomere shortening and the role of oxidative stress. Mech. Ageing Dev. 123, 351\u2013363 (2002).","journal-title":"Mech. Ageing Dev."},{"key":"BFnm2807_CR137","first-page":"3800","volume":"117","author":"T Liu","year":"2007","unstructured":"Liu, T. et al. Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice. J. Clin. Invest. 117, 3800\u20133809 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnm2807_CR138","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20100035","volume":"207","author":"G Liu","year":"2010","unstructured":"Liu, G. et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 207, 1589\u20131597 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnm2807_CR139","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980\u2013984 (2008).","journal-title":"Nature"},{"key":"BFnm2807_CR140","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-05-0137","volume":"65","author":"JA Chan","year":"2005","unstructured":"Chan, J.A., Krichevsky, A.M. & Kosik, K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65, 6029\u20136033 (2005).","journal-title":"Cancer Res."},{"key":"BFnm2807_CR141","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1172\/JCI43604","volume":"120","author":"DM Patrick","year":"2010","unstructured":"Patrick, D.M. et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J. Clin. Invest. 120, 3912\u20133916 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnm2807_CR142","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1681\/ASN.2010020134","volume":"21","author":"AC Chung","year":"2010","unstructured":"Chung, A.C., Huang, X.R., Meng, X. & Lan, H.Y. miR-192 mediates TGF-\u03b2\/Smad3-driven renal fibrosis. J. Am. Soc. Nephrol. 21, 1317\u20131325 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnm2807_CR143","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/ncb1897","volume":"11","author":"M Kato","year":"2009","unstructured":"Kato, M. et al. TGF-\u03b2 activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol. 11, 881\u2013889 (2009).","journal-title":"Nat. Cell Biol."},{"key":"BFnm2807_CR144","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.27443","volume":"62","author":"B Maurer","year":"2010","unstructured":"Maurer, B. et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum. 62, 1733\u20131743 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnm2807_CR145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","volume":"53","author":"C Roderburg","year":"2011","unstructured":"Roderburg, C. et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53, 209\u2013218 (2011).","journal-title":"Hepatology"},{"key":"BFnm2807_CR146","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","volume":"105","author":"E van Rooij","year":"2008","unstructured":"van Rooij, E. et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. USA 105, 13027\u201313032 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2807_CR147","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbrc.2009.11.056","volume":"391","author":"T Ogawa","year":"2010","unstructured":"Ogawa, T. et al. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem. Biophys. Res. Commun. 391, 316\u2013321 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm2807_CR148","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/rccm.200911-1698OC","volume":"182","author":"KV Pandit","year":"2010","unstructured":"Pandit, K.V. et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 182, 220\u2013229 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnm2807_CR149","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","volume":"104","author":"RF Duisters","year":"2009","unstructured":"Duisters, R.F. et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ. Res. 104, 170\u2013178 (2009).","journal-title":"Circ. Res."},{"key":"BFnm2807_CR150","doi-asserted-by":"crossref","first-page":"G101","DOI":"10.1152\/ajpgi.00220.2009","volume":"298","author":"SK Venugopal","year":"2010","unstructured":"Venugopal, S.K. et al. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G101\u2013G106 (2010).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnm2807_CR151","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/db10-0892","volume":"60","author":"B Wang","year":"2011","unstructured":"Wang, B. et al. miR-200a Prevents renal fibrogenesis through repression of TGF-\u03b22 expression. Diabetes 60, 280\u2013287 (2011).","journal-title":"Diabetes"},{"key":"BFnm2807_CR152","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1586\/ers.11.52","volume":"5","author":"L Richeldi","year":"2011","unstructured":"Richeldi, L. & du Bois, R.M. Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY program. Expert Rev. Respir. Med. 5, 473\u2013481 (2011).","journal-title":"Expert Rev. Respir. Med."},{"key":"BFnm2807_CR153","doi-asserted-by":"crossref","first-page":"L151","DOI":"10.1152\/ajplung.00389.2006","volume":"293","author":"H Nakanishi","year":"2007","unstructured":"Nakanishi, H., Sugiura, T., Streisand, J.B., Lonning, S.M. & Roberts, J.D. Jr. TGF-\u03b2\u2013neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung. Am. J. Physiol. Lung Cell Mol. Physiol. 293, L151\u2013L161 (2007).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"BFnm2807_CR154","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0092-8674(00)80545-0","volume":"96","author":"JS Munger","year":"1999","unstructured":"Munger, J.S. et al. The integrin \u03b1v\u03b26 binds and activates latent TGF-\u03b21: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319\u2013328 (1999).","journal-title":"Cell"},{"key":"BFnm2807_CR155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2353\/ajpath.2007.060158","volume":"170","author":"K Hahm","year":"2007","unstructured":"Hahm, K. et al. \u03b1v\u03b26 integrin regulates renal fibrosis and inflammation in Alport mouse. Am. J. Pathol. 170, 110\u2013125 (2007).","journal-title":"Am. J. Pathol."},{"key":"BFnm2807_CR156","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/157488809789649223","volume":"4","author":"K Hemavathy","year":"2009","unstructured":"Hemavathy, K. & Wang, J.C. Epigenetic modifications: new therapeutic targets in primary myelofibrosis. Curr. Stem Cell Res. Ther. 4, 281\u2013286 (2009).","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"BFnm2807_CR157","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.ultrasmedbio.2008.01.013","volume":"34","author":"JL Tedstone","year":"2008","unstructured":"Tedstone, J.L., Richards, S.M., Garman, R.D. & Ruzek, M.C. Ultrasound imaging accurately detects skin thickening in a mouse scleroderma model. Ultrasound Med. Biol. 34, 1239\u20131247 (2008).","journal-title":"Ultrasound Med. Biol."},{"key":"BFnm2807_CR158","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.cca.2011.08.008","volume":"412","author":"M Kono","year":"2011","unstructured":"Kono, M. et al. Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF). Clin. Chim. Acta 412, 2211\u20132215 (2011).","journal-title":"Clin. Chim. Acta"},{"key":"BFnm2807_CR159","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1681\/ASN.2007020196","volume":"18","author":"JP Prad\u00e8re","year":"2007","unstructured":"Prad\u00e8re, J.P. et al. LPA1 receptor activation promotes renal interstitial fibrosis. J. Am. Soc. Nephrol. 18, 3110\u20133118 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnm2807_CR160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nm1685","volume":"14","author":"AM Tager","year":"2008","unstructured":"Tager, A.M. et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat. Med. 14, 45\u201354 (2008).","journal-title":"Nat. Med."},{"key":"BFnm2807_CR161","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","volume":"9","author":"M Zeisberg","year":"2003","unstructured":"Zeisberg, M. et al. BMP-7 counteracts TGF-\u03b21\u2013induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9, 964\u2013968 (2003).","journal-title":"Nat. Med."},{"key":"BFnm2807_CR162","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00228-011-1043-2","volume":"67","author":"PN Sidharta","year":"2011","unstructured":"Sidharta, P.N., van Giersbergen, P.L., Halabi, A. & Dingemanse, J. Macitentan: entry-into-humans study with a new endothelin receptor antagonist. Eur. J. Clin. Pharmacol. 67, 977\u2013984 (2011).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BFnm2807_CR163","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm.2208","volume":"16","author":"V Barry-Hamilton","year":"2010","unstructured":"Barry-Hamilton, V. et al. Allosteric inhibition of lysyl oxidase\u2013like-2 impedes the development of a pathologic microenvironment. Nat. Med. 16, 1009\u20131017 (2010).","journal-title":"Nat. Med."},{"key":"BFnm2807_CR164","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/07853890801986594","volume":"40","author":"J Myllyharju","year":"2008","unstructured":"Myllyharju, J. Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets. Ann. Med. 40, 402\u2013417 (2008).","journal-title":"Ann. Med."},{"key":"BFnm2807_CR165","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1165\/rcmb.2007-0320OC","volume":"39","author":"S Fineschi","year":"2008","unstructured":"Fineschi, S. et al. In vivo investigations on antifibrotic potential of proteasome inhibition in lung and skin fibrosis. Am. J. Respir. Cell Mol. Biol. 39, 458\u2013465 (2008).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFnm2807_CR166","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/hep.21036","volume":"43","author":"A Anan","year":"2006","unstructured":"Anan, A. et al. Proteasome inhibition induces hepatic stellate cell apoptosis. Hepatology 43, 335\u2013344 (2006).","journal-title":"Hepatology"},{"key":"BFnm2807_CR167","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics, R. et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N. Engl. J. Med. 352, 1779\u20131790 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2807_CR168","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1164\/rccm.200906-0964OC","volume":"181","author":"CE Daniels","year":"2010","unstructured":"Daniels, C.E. et al. Imatinib treatment for idiopathic pulmonary fibrosis: randomized placebo-controlled trial results. Am. J. Respir. Crit. Care Med. 181, 604\u2013610 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnm2807_CR169","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/art.23696","volume":"58","author":"J Kay","year":"2008","unstructured":"Kay, J. & High, W.A. Imatinib mesylate treatment of nephrogenic systemic fibrosis. Arthritis Rheum. 58, 2543\u20132548 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnm2807_CR170","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","volume":"365","author":"L Richeldi","year":"2011","unstructured":"Richeldi, L. et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N. Engl. J. Med. 365, 1079\u20131087 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2807_CR171","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1158\/1078-0432.CCR-09-2836","volume":"16","author":"S Verstovsek","year":"2010","unstructured":"Verstovsek, S. Therapeutic potential of Janus-activated kinase-2 inhibitors for the management of myelofibrosis. Clin. Cancer Res. 16, 1988\u20131996 (2010).","journal-title":"Clin. Cancer Res."},{"key":"BFnm2807_CR172","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/hep.21561","volume":"45","author":"PJ Pockros","year":"2007","unstructured":"Pockros, P.J. et al. Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-\u03b31b in chronic hepatitis C patients with advanced fibrosis or cirrhosis. Hepatology 45, 569\u2013578 (2007).","journal-title":"Hepatology"},{"key":"BFnm2807_CR173","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1164\/rccm.201105-0813ED","volume":"184","author":"PW Noble","year":"2011","unstructured":"Noble, P.W., Richeldi, L. & Kaminski, N. End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 184, 4\u20135 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnm2807_CR174","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3346\/jkms.2009.24.4.614","volume":"24","author":"SW Park","year":"2009","unstructured":"Park, S.W. et al. Interleukin-13 and its receptors in idiopathic interstitial pneumonia: clinical implications for lung function. J. Korean Med. Sci. 24, 614\u2013620 (2009).","journal-title":"J. Korean Med. Sci."},{"key":"BFnm2807_CR175","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","volume":"365","author":"J Corren","year":"2011","unstructured":"Corren, J. et al. Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 365, 1088\u20131098 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2807_CR176","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1056\/NEJMe1108666","volume":"365","author":"M Kraft","year":"2011","unstructured":"Kraft, M. Asthma phenotypes and interleukin-13\u2014moving closer to personalized medicine. N. Engl. J. Med. 365, 1141\u20131144 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2807_CR177","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1755-1536-4-23","volume":"4","author":"JE Ekert","year":"2011","unstructured":"Ekert, J.E. et al. Chemokine (C-C motif) ligand-2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes. Fibrogenesis Tissue Repair 4, 23 (2011).","journal-title":"Fibrogenesis Tissue Repair"},{"key":"BFnm2807_CR178","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1358\/dnp.2010.23.5.1444206","volume":"23","author":"JS Duffield","year":"2010","unstructured":"Duffield, J.S. & Lupher, M.L. Jr. PRM-151 (recombinant human serum amyloid P\/pentraxin 2) for the treatment of fibrosis. Drug News Perspect. 23, 305\u2013315 (2010).","journal-title":"Drug News Perspect."},{"key":"BFnm2807_CR179","doi-asserted-by":"crossref","first-page":"5ra13","DOI":"10.1126\/scitranslmed.3000111","volume":"1","author":"AP Casta\u00f1o","year":"2009","unstructured":"Casta\u00f1o, A.P. et al. Serum amyloid P inhibits fibrosis through Fc\u03b3R-dependent monocyte-macrophage regulation in vivo. Sci. Transl. Med. 1, 5ra13 (2009).","journal-title":"Sci. Transl. Med."},{"key":"BFnm2807_CR180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","volume":"52","author":"TA McKinsey","year":"2012","unstructured":"McKinsey, T.A. Therapeutic potential for HDAC inhibitors in the heart. Annu. Rev. Pharmacol. Toxicol. 52, 303\u2013319 (2012).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"BFnm2807_CR181","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.110.221069","volume":"107","author":"ML Dart","year":"2010","unstructured":"Dart, M.L. et al. Interleukin-17\u2013dependent autoimmunity to collagen type V in atherosclerosis. Circ. Res. 107, 1106\u20131116 (2010).","journal-title":"Circ. Res."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.2807.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2807","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2807.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:04:49Z","timestamp":1687565089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.2807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":181,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFnm2807"],"URL":"https:\/\/doi.org\/10.1038\/nm.2807","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718405483.793556757","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}